LASERS, MICROBIOLOGY AND DENTAL MATERIALS IN CLINICAL DENTAL PRACTICE
Professor Laurence Walsh AO
Emeritus Professor, School of Dentistry, University of Queensland &
Adjunct Professor, Griffith University, Queensland &
Chief Dental Officer, Dentroid
RESEARCHER PROFILE
Filmed in Brisbane, Queensland, Australia | December 2024
Prof Walsh is a well known senior dental academic and dental board registered specialist in special needs dentistry. He completed his basic dental training and his PhD at the University of Queensland and then his post doctoral education at the University of Pennsylvania School of Medicine, followed by executive education at Stanford University and Harvard University. In addition to his multiple dental and educational qualifications, Prof Walsh is a member of the Australian Institute of Safety and Health, and an associate member of the Australian Institute of Physics. He has served for over 25 years as a laser safety officer. Prof Walsh was a member of the UQ Centre for Laser Science for 11 years.
Prof Walsh has one major national awards for research and teaching excellence, and has been made a life member of the ANZ Academy of special needs dentistry, and the Australian Dental Association. In 2018, he was appointed as an officer of the order of Australia (AO) in recognition of his contributions to dental education and dental research.
Prof Walsh has served on the academic staff of the University of Queensland School of Dentistry for 40 years, including for 21 years as the research group leader in advanced technologies. Since retiring from UQ in 2020 and then being appointed as an emeritus professor, Prof Walsh has continued his involvement with specialist training and clinical research at UQ, and continued applied research in advanced technologies.
Prof Walsh was Australia’s first multi-wavelength laser user in 1988, and he has published over 100 articles and 3 textbooks on the topic of laser dentistry. He has a further 300 journal publications on other topics, and his published work has attracted over 20,000 citations in the literature. Based on citation impact, in October 2023 Prof Walsh was ranked in the top 5 Australian dental scientists of all time in the Stanford University listing of the world’s top 2% of scientists.
Prof Walsh has represented the Australian Dental Association on multiple committees of Standards Australia since 1992 (including laser safety). He has taught laser safety and clinical laser procedures around the world for over 30 years. Prof Walsh has been the president of the Australian Association for laser dentistry since 2018.
-
Health and economic burden of interstitial lung diseases
Dr Cox’s main research interests focus on respiratory diseases and primarily on the economic burden and economic evaluation of interventions and treatments for their management. She earned her PhD from the University of Tasmania where her doctoral research examined the health and economic burden of idiopathic pulmonary fibrosis (IPF) in Australia, one component of the NHMRC Centre for Research Excellence for Pulmonary Fibrosis, a national project implemented alongside the Australian IPF Registry and the Lung Foundation Australia. This research provided the first epidemiological profile and first costing estimates of the economic burden of the disease in Australia, providing essential evidence for health service reimbursement policies.
-
Liver cancer & patient-derived tumour organoids
Dr Benjamin Dwyer is a translational cancer researcher driven by a clear purpose: to ensure discoveries made in the laboratory genuinely improve outcomes for patients.
Based at Curtin University, he established and now leads the organoid platform within the Liver Cancer Collaborative and directs the WA Organoid Innovation Hub, working at the intersection of biology, medicine and biotechnology to accelerate new treatments for liver cancer.
-
Oral administration of insulin for Type 1 Diabetes
Huiwen Pang is a 3rd year PhD candidate in the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, focusing on biomedical health research. Prior to commencing his PhD, Huiwen studied animal genetics in his Masters degree at Huazhong Agriculture University in China.
People with diabetes, especially Type 1 diabetes, largely rely on the insulin injections or insulin pumps to control their high blood glucose levels, which is painful and has a high risk of infections.
Huiwen Pang is conducting research on nano-based drug formulations for Type 1 diabetes treatment, with a focus on using nanomaterials to load insulin for oral administration and employing anti-apoptotic and anti-inflammatory approaches to mitigate damage to beta cells.
